The science of what the drug does to the body and what the body does to the drug.
The Pharmacology Department is the Universitas Scholarium’s faculty of drugs and their action — the science of what a substance does to the body and what the body does to it. Its scope runs from the ancient herbalists who catalogued the healing plants to the molecular pharmacologists who found the receptors on which drugs act. The faculty trace that long passage from materia medica to molecular mechanism. Its ancient authorities — Dioscorides, whose herbal ruled for sixteen centuries, Galen, and Avicenna — built the first systematic pharmacopoeias. Paracelsus insisted that the dose makes the poison, founding toxicology. The modern science begins with John Newport Langley, who proposed the receptor, and Paul Ehrlich, who imagined the “magic bullet” and founded chemotherapy; Louis Lewin charted the psychoactive drugs, and Candace Pert discovered the opiate receptor. Each is an AI simulacrum that reasons in its progenitor’s scientific idiom. The department is for the study of pharmacology as a science, not for medical or dosing advice.
Materia Medica — the Ancient and Medieval Pharmacopoeia
Fifteen centuries of describing what a substance does without any account of how it does it. The work is identification, field observation and correction of one’s predecessors — and it is careful, cumulative and genuinely empirical.
Botany · De Historia Plantarum · Medicinal Plants · Aristotelian Natural History
Theophrastus, Aristotle’s successor as head of the Lyceum, wrote the first systematic botanical texts in Western history: Historia Plantarum and De Causis Plantarum. He described over 500 plant species, classified them by their medicinal properties, and distinguished between the poisonous and the therapeutic. He is the father of botany and the grandfather of pharmacognosy. His observation that the dose makes the difference between medicine and poison predates Paracelsus by eighteen centuries.
Can help you with: Ancient Greek botanical knowledge, plant classification and medicinal properties, the foundations of pharmacognosy, the relationship between natural philosophy and medicine in antiquity, and the history of botanical texts from Theophrastus to Dioscorides.
→ Converse with Theophrastus of Eresus
De Materia Medica · Pharmacology · Field Observation · The Pharmacopoeia
Dioscorides was a military physician in the Roman army who compiled De Materia Medica — a systematic description of approximately 600 plants, 35 animal products, and 90 minerals with their medicinal uses. It was the primary reference in pharmacy for fifteen hundred years. He was the first to organise materia medica by plant family rather than alphabetically, noting that related plants tend to have related effects. Copies of his text, with increasingly inaccurate illustrations, were the standard pharmaceutical reference from antiquity through the Renaissance.
Can help you with: De Materia Medica and its contents, ancient pharmacognosy, the history of botanical medicine from Rome through the Islamic world to Renaissance Europe, plant classification by effect, the problem of textual corruption in manuscript traditions, and the history of pharmaceutical botany.
→ Converse with Pedanius Dioscorides
Compound Drugs · Four Qualities · Degree Theory · The Physician-Philosopher
Galen was the most influential physician-pharmacologist of antiquity and the dominant authority in European medicine until the sixteenth century. He extended Dioscorides’s materia medica with his own clinical observations, developed the doctrine of degrees (plants act hot, cold, wet, or dry in four degrees of intensity), and systematised compound medicines. His pharmacy was rational within the limits of humoral theory: he understood drug action in terms of qualities that could be combined and balanced. More than half the plants he described are still in active pharmaceutical use.
Can help you with: Galenic pharmacy and its theoretical basis, the doctrine of qualities and degrees, compound medicines and their rationale, the transmission of ancient pharmacology through Arabic and medieval European medicine, and why Galenic pharmacology persisted for fourteen centuries.
→ Converse with Galen of Pergamon
Canon of Medicine · Drug Testing Rules · Tajribah · The Philosopher-Physician
Ibn Sina’s Canon of Medicine (1025) contained in its fifth book the most comprehensive pharmacopoeia of the medieval world: 760 drugs, with their properties, preparations, and uses, organised systematically. He also described clinical trials: test drugs on simple diseases, control for other variables, and observe multiple cases before drawing conclusions. This is the earliest systematic statement of controlled clinical experimentation. His pharmacology was Arabic at its foundation but incorporated Greek, Indian, and Persian traditions.
Can help you with: The Canon of Medicine and its pharmacological sections, medieval Islamic pharmacy, the systematic evaluation of drug effects, the transmission of Greek medicine into Arabic, Ibn Sina’s approach to clinical methodology, and the relationship between Islamic and European medieval medicine.
→ Converse with Ibn Sina (Avicenna)
Kitab al-Jami · 300 New Plants · Field Pharmacology · Correcting Dioscorides
Ibn al-Baitar compiled the most comprehensive pharmacognosy of the medieval Islamic world: his Comprehensive Book on Simple Drugs and Foods described nearly 1,400 plant, animal, and mineral products, including some 300 not previously described. He travelled across North Africa, Andalusia, and the Levant collecting specimens and comparing local knowledge. His approach was systematic and critical: he compared his observations with Dioscorides, Galen, and earlier Islamic writers, noting agreements and discrepancies. He was the last great pharmacognosist of classical Islamic medicine.
Can help you with: Medieval Islamic pharmacognosy, the expansion of materia medica beyond the Greek tradition, the comparative method in botany, North African and Andalusian medicinal plants, the relationship between empirical observation and classical authority in medieval pharmacy, and the history of the Islamic medical tradition.
→ Converse with Ibn al-Baitar
Dose, Chemistry and the Classification of Effect
The turn from what a plant is to what a quantity does. Sola dosis facit venenum — only the dose makes the poison — and, three centuries later, the first systematic classification of psychoactive substances by the effect they produce rather than the plant they come from.
Sola Dosis Facit Venenum · Iatrochemistry · The Tria Prima · The Basel Bonfire
Paracelsus stated toxicology’s foundational principle — “all things are poison, and nothing is without poison; the dose alone determines what is not a poison” — and applied it to medicine. He replaced Galenic herbal pharmacy with mineral remedies and insisted that disease was a specific chemical disorder requiring a specific chemical treatment, not a systemic imbalance requiring a balanced remedy. He was the founder of iatrochemistry (chemistry applied to medicine) and the first to describe occupational diseases (miner’s lung). His pharmacology was brilliant, eccentric, and partly wrong.
Can help you with: The dose-response relationship, iatrochemistry and its principles, the history of mineral remedies in medicine, Paracelsus’s critique of Galenic medicine, occupational disease and its history, the chemical theory of disease, and the relationship between alchemy and pharmacy.
→ Converse with Paracelsus
Phantastica · Psychoactive Classification · Ethnobotanical Pharmacology · Anhalonium
Lewin was the first systematic pharmacologist of psychoactive plants. His Phantastica: Narcotic and Stimulating Drugs (1924) classified psychoactive plants by their effects (euphoriants, phantastica, hypnotics, inebriants, excitants) and described their pharmacology, botany, history, and ethnobotany with unprecedented thoroughness. He also wrote the definitive early study of cocaine and produced important work on methanol poisoning. He was a professor in Berlin who was dismissed by the Nazis in 1933 and died the following year.
Can help you with: Phantastica and its classification system, the early pharmacology of cocaine, opium, and other psychoactives, the history of ethnobotany, the relationship between pharmacology and ethnography, methanol toxicology, and the development of psychopharmacology as a discipline.
→ Converse with Louis Lewin
The Receptor — What a Drug Acts On
The hinge of the whole subject. A receptive substance in the tissue, and a side-chain that binds selectively: once a drug is understood to act on something specific, a drug can be aimed. Everything downstream is a consequence of this idea.
Receptive Substances · Autonomic Nervous System · Nicotine-Curare · Chemical Transmission
Langley developed receptor theory. Studying the effects of pilocarpine and atropine on salivary glands in the 1870s, he observed that the two drugs had opposite effects that cancelled each other, and proposed that both acted on a specific “receptive substance” in the cell. This was the first formulation of the receptor concept. He later used nicotine and curare to map the autonomic nervous system and showed that ganglionic transmission involved a receptive substance distinct from the nerve itself. His concept is the foundation of all modern pharmacology.
Can help you with: Receptor theory and its origins, the autonomic nervous system and its pharmacology, the use of competitive antagonists to identify receptors, the history of the receptor concept from Langley to Ehrlich, and the relationship between physiology and pharmacology.
→ Converse with John Newport Langley
The Magic Bullet · Side-Chain Theory · Salvarsan · Receptor Concept · Drug Resistance
Ehrlich invented the concept of the magic bullet: a chemical that would kill a pathogen without harming the host. His systematic screening of hundreds of organometal compounds led to Salvarsan (compound 606, 1909) — the first effective treatment for syphilis. He also developed the lock-and-key model of drug-receptor interaction, stained bacteria to differentiate them (founding bacteriological staining), and contributed to immunology. He established rational drug design as a discipline: identify a target, synthesise candidates, test systematically, iterate.
Can help you with: Rational drug design methodology, Salvarsan and the history of chemotherapy, receptor theory and the lock-and-key model, bacteriological staining and its history, the systematic screening approach to drug discovery, and the founding principles of modern pharmaceutical research.
→ Converse with Paul Ehrlich
Alpha & Beta Receptors · Receptor Subtype Classification · The Rejected Paper
Ahlquist proposed in 1948 that the effects of adrenaline on different tissues were mediated by two types of receptors, which he called alpha and beta adrenoreceptors. The proposal, rejected by the major pharmacology journal as “speculation,” was finally proved correct when James Black developed propranolol — the first selective beta blocker — in 1964. The alpha-beta classification remains the basis of adrenergic pharmacology, beta blockers are among the most widely prescribed drugs in history, and Ahlquist’s original paper is a classic of receptor theory.
Can help you with: Alpha and beta adrenergic receptors, the pharmacology of adrenaline and noradrenaline, receptor subtype classification, the history of beta blockers, the relationship between receptor theory and drug design, and how a correct but speculative hypothesis can sit unrecognised for fifteen years.
→ Converse with Raymond Ahlquist
Opioid Receptor · Radioligand Binding · Endorphins · Molecules of Emotion
American neuroscientist who identified the opiate receptor in 1973 at the age of twenty-six, as a graduate student in Solomon Snyder’s laboratory at Johns Hopkins. Her radioligand binding assay demonstrated that opiates act by binding to specific receptors in the brain — which implied that the brain must produce its own endogenous opioids (later identified as endorphins and enkephalins). The discovery opened the field of neuropeptide pharmacology. The credit question — Snyder was nominated for the Lasker Prize; Pert was not — became a landmark case in scientific authorship ethics.
Can help you study: The opioid receptor, radioligand binding, endorphins, neuropeptide pharmacology, the Snyder-Pert credit dispute, and the argument that the person who does the experiment deserves the recognition.
→ Converse with Candace Pert
Chemical Transmission & the Antibiotics
Two lines running in parallel through the same decades — the discovery that nerves speak chemically, and the discovery that a mould, a soil bacterium and a dye could each kill a pathogen without killing the patient.
Vagusstoff · Chemical Neurotransmission · The Easter Dream · Acetylcholine
Loewi proved chemical neurotransmission in an experiment he designed in a dream on Easter Sunday 1921. He stimulated a frog’s vagus nerve, collected the perfusate from its heart, applied it to a second heart, and showed that the substance released slowed the second heart — proving that the vagus acted by releasing a chemical (acetylcholine), not by direct electrical transmission. He shared the Nobel Prize with Dale in 1936. The experiment itself — elegant, minimal, decisive — is one of the most beautiful in the history of neuroscience. He was arrested by the Gestapo in 1938 and escaped to Britain.
Can help you with: The discovery of chemical neurotransmission, the frog heart experiment and its design, acetylcholine and the vagus nerve, the history of synaptic transmission, the dream that generated the experimental design, and Loewi’s escape from Nazi Austria.
→ Converse with Otto Loewi
Acetylcholine · Cholinergic/Adrenergic · Histamine · Peripheral Transmission
Dale shared the Nobel Prize with Loewi for work on chemical neurotransmission, specifically for characterising acetylcholine: he identified it in ergot extracts, showed it was released at nerve terminals, and demonstrated its action at muscarinic and nicotinic receptors. He also developed the principle of Dale’s law: a neuron releases the same neurotransmitter at all its synapses (later shown to be approximately but not exactly true). He was director of the Wellcome Physiological Research Laboratories and later the National Institute for Medical Research.
Can help you with: Acetylcholine pharmacology, muscarinic and nicotinic receptors and their distinction, Dale’s law, the history of neurotransmission, the Wellcome research tradition in pharmacology, and the relationship between industrial pharmaceutical research and academic science.
→ Converse with Henry Hallett Dale
Prontosil · Sulfonamides · The First Synthetic Antibacterial · The Industrial Screen
Domagk discovered the sulfonamides — the first class of effective antibacterial drugs — in 1932, when he showed that Prontosil (a red dye) protected mice from streptococcal infection. He used Prontosil to save his daughter’s life when she developed severe streptococcal septicaemia. The active component, sulfanilamide, was shown to work by mimicking PABA (para-aminobenzoic acid), which bacteria need for folic acid synthesis. He received the Nobel Prize in 1939 but was prevented from accepting it by the Nazi government. He accepted it in 1947.
Can help you with: Sulfonamide pharmacology and the mechanism of action, the discovery of Prontosil, antimetabolite theory, the history of antibacterial drug development before penicillin, the Nazi suppression of the Nobel Prize, and the relationship between industrial dye chemistry and pharmaceutical discovery.
→ Converse with Gerhard Domagk
Penicillin · The Contaminated Plate · Serendipity · The Resistance Warning
Fleming discovered penicillin in 1928 when he noticed that a contaminating mould had killed the staphylococci surrounding it on an agar plate. He published the observation but lacked the chemistry to extract and purify the active substance. Penicillin remained a laboratory curiosity until Florey and Chain developed it into a therapeutic agent in 1940–1941. Fleming received the Nobel Prize in 1945 with Florey and Chain. His contribution was the observation; the drug required a decade of chemical and biological work by others to realise.
Can help you with: The discovery of penicillin and its history, the relationship between Fleming’s observation and the Florey-Chain development, the history of antibiotics, the role of serendipity in pharmaceutical discovery, the penicillin patents and their political history, and the transition from laboratory observation to clinical medicine.
→ Converse with Alexander Fleming
Streptomycin · Soil Microbiology · The Word "Antibiotic" · Systematic Drug Discovery
Waksman coined the term “antibiotic” and discovered streptomycin — the first effective treatment for tuberculosis — in 1943, systematically screening soil bacteria for substances that killed pathogens. He won the Nobel Prize in 1952 in a controversy: his graduate student Albert Schatz had done much of the experimental work and had been promised a share of the royalties, which Waksman then denied him. The dispute became a landmark case in the ethics of scientific credit and intellectual property. Waksman’s systematic soil-screening method remains the basis of antibiotic discovery.
Can help you with: The discovery of streptomycin, systematic antibiotic discovery from soil bacteria, the definition of antibiotic, tuberculosis and its treatment history, the Waksman-Schatz dispute and its implications for scientific credit, and the soil as a source of pharmaceutical compounds.
→ Converse with Selman Waksman
Rational Drug Design
Designing the molecule from the mechanism rather than screening for it — antimetabolites, the beta-blocker built to fit a receptor subtype, the statin found by asking what a fungus would use against a competitor, and the metabolism work that made any of it predictable.
Drug Metabolism · Biochemical Pharmacology · Reserpine · Serotonin · The Laboratory Dynasty
Brodie founded pharmacokinetics — the quantitative study of how drugs move through the body: absorption, distribution, metabolism, and excretion. His work in the 1940s and 1950s showed that drug duration of action depends primarily on metabolic inactivation, that drugs distribute unequally between tissues, and that liver metabolism is the primary route of drug inactivation. He also showed that aspirin’s effects and its gastric toxicity are mediated by different mechanisms. His laboratory trained most of the next generation of American pharmacologists.
Can help you with: Pharmacokinetics and its principles, drug metabolism and its clinical importance, the relationship between drug structure and duration of action, tissue distribution, the discovery of serotonin, and the history of modern pharmacology in America.
→ Converse with Bernard Brodie
Rational Drug Design · Antimetabolites · Nucleic Acid Metabolism · Programme Architecture
Hitchings developed rational drug design as a systematic methodology. Working at Burroughs Wellcome with Gertrude Elion from the 1940s, he targeted the nucleic acid synthesis pathways that proliferating cells (including pathogens and tumour cells) depend on more than normal cells. This produced thioguanine (leukaemia), trimethoprim (bacterial infections), azathioprine (organ transplant immunosuppression), and acyclovir (herpes). Each drug was designed from first principles of biochemistry, not discovered by random screening. He shared the Nobel Prize with Elion and James Black in 1988.
Can help you with: Rational drug design and its methodology, antimetabolite pharmacology, nucleic acid synthesis as a drug target, the history of immunosuppression and organ transplantation, trimethoprim and its mechanism, and the relationship between biochemistry and drug discovery.
→ Converse with George Hitchings
Rational Drug Design · Acyclovir · 6-Mercaptopurine · Azathioprine · Selective Toxicity
Elion co-developed with George Hitchings the rational drug design approach that produced some of the most important drugs of the twentieth century. Her personal contributions include 6-mercaptopurine (childhood leukaemia, first effective treatment), azathioprine (organ transplant immunosuppression, enabling the entire transplant era), allopurinol (gout), acyclovir (herpes), and AZT (HIV, though she had retired). She never completed a PhD — she was denied a place in graduate school twice because of her gender — and worked in industry rather than academia for her entire career.
Can help you with: Rational drug design, purine analogue pharmacology, the history of childhood leukaemia treatment, organ transplantation and immunosuppression, antiviral drug development, the Nobel Prize in an industrial research context, and the systematic exclusion of women from academic science in the mid-twentieth century.
→ Converse with Gertrude Elion
Dopamine · Reserpine-L-DOPA Proof · Parkinson's · SSRIs · CNS Pharmacology
Carlsson proved that dopamine is a neurotransmitter in its own right (not merely a precursor to noradrenaline), showed that reserpine depletes dopamine causing Parkinson-like symptoms, and demonstrated that L-DOPA restores dopamine levels and reverses those symptoms. His work opened the dopamine hypothesis of Parkinson’s disease, the dopamine theory of schizophrenia, and the whole field of neuropsychopharmacology. He received the Nobel Prize in 2000. He was still publishing original research in his eighties.
Can help you with: Dopamine as a neurotransmitter, the pathophysiology of Parkinson’s disease, L-DOPA therapy, the dopamine hypothesis of schizophrenia, the history of antipsychotic drugs, neuropsychopharmacology and its founding, and the relationship between basic neuroscience and clinical psychiatry.
→ Converse with Arvid Carlsson
Beta-Blockers · H2 Antagonists · Propranolol · Cimetidine · Receptor-Based Drug Design
Black invented two of the most important classes of drugs of the twentieth century by applying Ahlquist’s receptor theory to drug design. Propranolol (1964), the first beta blocker, targeted cardiac beta receptors to treat angina and hypertension. Cimetidine (1976), the first H2 antagonist, blocked histamine receptors in the stomach to treat peptic ulcers without surgery. Both drugs were designed from first principles of receptor pharmacology rather than discovered by screening. Black received the Nobel Prize in 1988 with Hitchings and Elion. His approach proved that understanding receptors makes drug design tractable.
Can help you with: Beta blockers and their design, H2 receptor antagonists, receptor-targeted drug design, the history of angina and hypertension treatment, the treatment of peptic ulcers before and after cimetidine, the 1988 Nobel Prize, and the application of receptor pharmacology to therapeutic development.
→ Converse with James Black
Statins · HMG-CoA Reductase · Cholesterol Biosynthesis · Compactin
Endo discovered the statins — the most widely prescribed class of drugs in history — by applying ecological reasoning. He hypothesised that fungi competing with cholesterol-synthesising bacteria might produce inhibitors of cholesterol synthesis. He screened 6,000 fungal cultures and isolated compactin (mevastatin) in 1973, a potent inhibitor of HMG-CoA reductase, the enzyme that controls cholesterol biosynthesis. His employer Sankyo terminated the clinical programme; Merck independently developed lovastatin and captured the commercial benefit. Endo received neither a Nobel Prize nor significant financial reward from his discovery, which has prevented millions of heart attacks.
Can help you with: Statin pharmacology and the HMG-CoA reductase pathway, cholesterol biosynthesis, the ecological reasoning behind Endo’s discovery, the history of the statin class from compactin to the present, the question of why Endo received no Nobel Prize, and the politics of drug development between academic discovery and commercial exploitation.
→ Converse with Akira Endo
